Ultomiris medication therapy is used to help manage certain rare immune related disorders by reducing harmful activity in the body’s complement system. This treatment is commonly prescribed for conditions such as paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Patients often receive the medication through intravenous infusion under medical supervision.
Ultomiris medication therapy is an advanced treatment option designed for people living with rare blood and immune system disorders. The medication works by targeting part of the immune system called the complement pathway, which can become overactive and damage healthy cells. Doctors prescribe Ultomiris to help reduce complications, improve quality of life, and support long term disease management for eligible patients.